Clinique Victor Hugo — Clinical Trial Site

88 Registered trials

35 Currently recruiting

Organisation

Clinique Victor Hugo

Location

Le Mans, France

Identifier

ORG-100032493

Address

Centre De Cancerologie De La Sarthe, 66 Rue De Degre, 72000, France

Departments

-
#3350: Hématologie
125008
2315 Oncology Medical
409: Hematologie
Biologie médicale
Breast Oncology
Centre Jean Bernard (Atlas), Clinique Victor Hugo
FR30004 Plateforme de Recherche, Clinique Département Investigation, Oncologie-Hematologie
Generalist Medicine
Haematology
Hématologie
Hématologie clinique
Hematology
Medecine nucleaire
Medical Oncology
Medical Oncology Department
N/A
Onco-Haematology
Onco-hématologie
ONCO-RADIOTHERAPY
ONCOLOGIE
Oncologie Médicale
Oncologie Radiothérapie
Oncologie Thérapeutique
Oncologie-Radiothérapie
Oncology
Oncology - radiotherapy
Oncology – radiotherapy
Oncology and Radiotherapy
Oncology radiotherapy
Oncology-Radiotherapy
Oncoloy-Radiotherapy
Radiotherapy
Radiotherapy - oncology
Radiotherapy_ Oncology
Radiotherapy-oncology
Radiothezapy - Oncology
Service d'oncologie médicale
Service de radiothérapie

Clinical trials at this site (88)

Search interface

Chemotherapy or chemotherapy + hormonotherapy in women over 70 with HER2 receptor-negative but estrogen receptor-positive breast cancer acco… Ended

2024-516996-34-00 oestrogen-receptor (ER)-positive HER2-negative breast c 5 2012-04-12
Study of Taxane-Platinum followed by a maintenance with avelumab and cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma… Halted

2023-510559-41-00 Recurrent or Metastatic Squamous Cell Carcinoma of the 4 2025-01-02
Study comparing radiotherapy combined with cetuximab + Xevinapant (study drug) with radiotherapy combined with cetuximab + placebo in patien… Ended

2022-502584-38-00 Locally advanced squamous cell carcinoma of the head an 5 2023-12-12
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN High Risk, Cisplatin-ineligible Participants (XRAY VISION) Ended

2023-508528-36-00 Resected squamous cell carcinoma of the head and neck 5 2022-12-16
A clinical study to test the safety and efficacy of GB1211 in combination with atezolizumab in patients with Non-Small Cell Lung Cancer (NSC… Ended

2024-514419-93-00 Study to investigate the safety and efficacy of GB1211 9 2022-05-19
Study to Compare Tivozanib in Combination with Nivolumab to Tivozanib Monotherapy in Subjects with Renal Cell Carcinoma Ended

2024-514570-43-00 Renal cell carcinoma 5 2022-01-24
The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic… Ended

2024-517251-12-00 Recurrent or metastatic head and neck squamous cell car 5 2021-11-02
A Multicenter, Open-Label, Phase I/II Study of EOS884448 in combination with standard of care and/or investigational therapies in participan… Ended

2024-512227-36-00 Advanced solid tumors 9 2021-07-28
Randomized trial evaluating adapted chemotherapy in patients with squamous carcinoma Ended

2024-512456-38-00 locally advanced squamous cell carcinoma 4 2021-02-04
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Ri… Ended

2023-504036-17-00 Chronic Lymphocytic Leukemia (CLL) 5 2020-05-07
A global study to evaluate peri-operative pembrolizumab with chemotherapy versus placebo to pembrolizumab plus chemotherapy in cisplatin eli… Ended

2022-501970-20-01 Cis-eligible Muscle-invasive bladder cancer. 5 2019-06-07
A RANDOMIZED TRIAL TESTING EARLY VERSUS LATE ONSET OF EPO ALFA TREATMENT IN LOWER RISK MDS WITH NON RBC TRANSFUSION DEPENDENT ANEMIA AND WI… Ended

2024-515356-21-00 Adult subject (18 years of age older) with low or inter 5 2018-04-17
A Study to Evaluate the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and CHP (R-CHP) Versus Rituximab and CHOP (… Ended

2024-516904-40-00 Previously Untreated Diffuse large B-cell lymphoma (DLB 5 2018-03-27
A Study of Venetoclax Co-Administered with Low Dose Cytarabine Versus Low Dose Cytarabine in Untreated Patients with Acute Myeloid Leukemia … Ended

2024-513630-37-00 Acute Myeloid Leukemia 5 2017-10-24
A Study to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and … Ended

2023-504034-22-00 Chronic Lymphocytic Leukemia (CLL) 5 2014-12-18
Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Ended

2024-512754-16-01 Prostate cancer 5